Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 135, Issue 2, Pages 335-336Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2014.420
Keywords
-
Categories
Ask authors/readers for more resources
Sequencing samples of melanoma for targetable mutations has become a standard of care for metastatic disease. In this issue, Siroy et al. demonstrate how clinical genetic analysis is moving from a single-gene Sanger-sequencing approach to targeted next-generation sequencing. They present data on a large cohort of patients with advanced melanoma, and their data support previous findings and also present novel aspects of melanoma genetics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available